- Home
- MSPR vs ALBT Comparison
MSPR vs ALBT Comparison
Compare MSPR & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSPR
- ALBT
- Stock Information
- Founded
- MSPR 2014
- ALBT 2014
- Country
- MSPR United States
- ALBT United States
- Employees
- MSPR N/A
- ALBT N/A
- Industry
- MSPR
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSPR
- ALBT Health Care
- Exchange
- MSPR NYSE
- ALBT Nasdaq
- Market Cap
- MSPR 5.3M
- ALBT 5.7M
- IPO Year
- MSPR N/A
- ALBT N/A
- Fundamental
- Price
- MSPR $0.98
- ALBT $2.27
- Analyst Decision
- MSPR
- ALBT
- Analyst Count
- MSPR 0
- ALBT 0
- Target Price
- MSPR N/A
- ALBT N/A
- AVG Volume (30 Days)
- MSPR 914.9K
- ALBT 662.4K
- Earning Date
- MSPR 08-13-2025
- ALBT 08-18-2025
- Dividend Yield
- MSPR N/A
- ALBT N/A
- EPS Growth
- MSPR N/A
- ALBT N/A
- EPS
- MSPR N/A
- ALBT N/A
- Revenue
- MSPR $13,085,000.00
- ALBT $807,235.00
- Revenue This Year
- MSPR N/A
- ALBT N/A
- Revenue Next Year
- MSPR N/A
- ALBT N/A
- P/E Ratio
- MSPR N/A
- ALBT N/A
- Revenue Growth
- MSPR 34.74
- ALBT N/A
- 52 Week Low
- MSPR $0.87
- ALBT $2.11
- 52 Week High
- MSPR $11.20
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- MSPR N/A
- ALBT 37.00
- Support Level
- MSPR N/A
- ALBT $2.15
- Resistance Level
- MSPR N/A
- ALBT $2.52
- Average True Range (ATR)
- MSPR 0.00
- ALBT 0.22
- MACD
- MSPR 0.00
- ALBT 0.00
- Stochastic Oscillator
- MSPR 0.00
- ALBT 12.00
About MSPR MSP RECOVERY INC
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.